ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $566,000 | +28.1% | 12,500 | 0.0% | 0.10% | +2.0% |
| Q3 2020 | $442,000 | -6.4% | 12,500 | 0.0% | 0.10% | -11.7% |
| Q2 2020 | $472,000 | +30.7% | 12,500 | 0.0% | 0.11% | +0.9% |
| Q1 2020 | $361,000 | -44.3% | 12,500 | 0.0% | 0.11% | -35.3% |
| Q4 2019 | $648,000 | -5.5% | 12,500 | 0.0% | 0.17% | +19.7% |
| Q3 2019 | $686,000 | +35.0% | 12,500 | 0.0% | 0.14% | +30.3% |
| Q2 2019 | $508,000 | +34.4% | 12,500 | 0.0% | 0.11% | +38.0% |
| Q1 2019 | $378,000 | -10.0% | 12,500 | 0.0% | 0.08% | -32.5% |
| Q4 2018 | $420,000 | -20.3% | 12,500 | 0.0% | 0.12% | 0.0% |
| Q3 2018 | $527,000 | +31.8% | 12,500 | 0.0% | 0.12% | +33.0% |
| Q2 2018 | $400,000 | -35.7% | 12,500 | 0.0% | 0.09% | -32.3% |
| Q1 2018 | $622,000 | -7.7% | 12,500 | 0.0% | 0.13% | -3.7% |
| Q4 2017 | $674,000 | -7.0% | 12,500 | 0.0% | 0.14% | +11.6% |
| Q3 2017 | $725,000 | +17.5% | 12,500 | 0.0% | 0.12% | +7.1% |
| Q2 2017 | $617,000 | +13.6% | 12,500 | 0.0% | 0.11% | +5.6% |
| Q1 2017 | $543,000 | -11.3% | 12,500 | 0.0% | 0.11% | -20.1% |
| Q4 2016 | $612,000 | +2.3% | 12,500 | 0.0% | 0.13% | -4.3% |
| Q3 2016 | $598,000 | -10.9% | 12,500 | 0.0% | 0.14% | -14.1% |
| Q2 2016 | $671,000 | +20.0% | 12,500 | 0.0% | 0.16% | +20.7% |
| Q1 2016 | $559,000 | +17.2% | 12,500 | 0.0% | 0.14% | +26.2% |
| Q4 2015 | $477,000 | +19.8% | 12,500 | 0.0% | 0.11% | +20.2% |
| Q3 2015 | $398,000 | -3.6% | 12,500 | 0.0% | 0.09% | +2.3% |
| Q2 2015 | $413,000 | -19.8% | 12,500 | 0.0% | 0.09% | -23.0% |
| Q1 2015 | $515,000 | +1.2% | 12,500 | 0.0% | 0.11% | 0.0% |
| Q4 2014 | $509,000 | +11.1% | 12,500 | 0.0% | 0.11% | -0.9% |
| Q3 2014 | $458,000 | -20.9% | 12,500 | 0.0% | 0.11% | -14.3% |
| Q2 2014 | $579,000 | +12.6% | 12,500 | 0.0% | 0.13% | +0.8% |
| Q1 2014 | $514,000 | +7.8% | 12,500 | 0.0% | 0.13% | +17.9% |
| Q4 2013 | $477,000 | +59.5% | 12,500 | 0.0% | 0.11% | +49.3% |
| Q3 2013 | $299,000 | +40.4% | 12,500 | 0.0% | 0.08% | +17.2% |
| Q2 2013 | $213,000 | – | 12,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |